This ability to halt or inhibit actions, known as response inhibition ... how different parts of the brain collaborate to regulate inhibitory control. Their findings revealed a four-step neural ...

Volastra Therapeutics has announced the preliminary data of its oral kinesin family member 18A (KIF18A) inhibitor, VLS-1488, ...

They discovered that the two immune checkpoint inhibitors combination regimens have different mechanisms of action mediated through different effects on CD4 T cells. The anti-PD-1/LAG-3 drug ...

Accropeutics’ oral, selective TYK2/JAK1 inhibitor AC-201 has met the primary and key secondary endpoints in a Phase II ...

NKT3447 is an orally bioavailable small molecule CDK2 inhibitor that exhibits high selectivity against CDK1 and other CDKs, prolonged pharmacodynamic effects, and a distinct mechanism of action.

Mechanism of action of the hepatitis B and D virus cell entry inhibitor bulevirtide deciphered. ScienceDaily . Retrieved June 1, 2025 from www.sciencedaily.com / releases / 2024 / 04 ...

Researchers from GSK plc presented the discovery and preclinical characterization of novel potent and selective inhaled phosphatidylinositol 4-kinase β (PI4Kβ) inhibitor being developed for the ...

ONCT-534 is a dual-action androgen receptor inhibitor (DAARI) that interacts with both the N-terminal domain and the ligand-binding domain (LBD) of the androgen receptor (AR), inhibiting cell ...